Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Gross Profit | 3,540 | 2,980 | 3,140 | 3,110 | 2,530 |
| Operating Expenses | 2,250 | 1,330 | 1,070 | 1,470 | 1,350 |
| Operating Income | -2,250 | -1,330 | -1,070 | -1,470 | -1,350 |
| Pre-tax Income | -2,250 | -1,330 | -1,070 | -1,470 | -1,350 |
| Net Income Continuous | -2,250 | -1,330 | -1,070 | -1,470 | -1,350 |
| Net Income | $-2,250 | $-1,330 | $-1,070 | $-1,470 | $-1,350 |
| EBITDA(a) | $-2,170 | $-1,290 | $-1,030 | $-1,430 | $-1,310 |